Asia-Pacific Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Opportunity Analysis and Industry Forecast, 2021–2030

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s five force analysis

3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Continuous decline in fertility rates

3.4.1.2.Delayed pregnancies in women

3.4.1.3.Technological advancements with respect to fertility treatment

3.4.2.Restraints

3.4.2.1.High treatment costs of ARTs in emerging countries

3.4.2.2.Inadequate reimbursement policies

3.4.3.Opportunity

3.4.3.1.Rise in fertility tourism

3.5.COVID-19 impact on the fertility services market

CHAPTER 4:FERTILITY SERVICES MARKET, BY PROCEDURE

4.1.Overview

4.1.1.Market size and forecast

4.2.IVF with ICSI

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast

4.3.IUI

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast

4.4.IVF without ICSI

4.4.1.Key market trends growth factors, and opportunities

4.4.2.Market size and forecast

4.5.Surrogacy

4.5.1.Key market trends, growth factors, and opportunities

4.5.2.Market size and forecast

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities

4.6.2.Market size and forecast

CHAPTER 5:FERTILITY SERVICES MARKET, BY SERVICE

5.1.Overview

5.1.1.Market size and forecast

5.2.Fresh non-donor

5.2.1.Key market trends, growth factors, and opportunities

5.2.2.Market size and forecast

5.3.Frozen non-donor

5.3.1.Key market trends, growth factors, and opportunities

5.3.2.Market size and forecast

5.4.Egg & embryo banking

5.4.1.Key market trends, growth factors, and opportunities

5.4.2.Market size and forecast

5.5.Fresh donor

5.5.1.Key market trends, growth factors, and opportunities

5.5.2.Market size and forecast

5.6.Frozen donor

5.6.1.Key market trends, growth factors, and opportunities

5.6.2.Market size and forecast

CHAPTER 6:FERTILITY SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Fertility clinics

6.2.1.Key market trends, growth factors, and opportunities

6.2.2.Market size and forecast

6.3.Hospitals

6.3.1.Key market trends, growth factors, and opportunities

6.3.2.Market size and forecast

6.4.Surgical centers

6.4.1.Key market trends, growth factors, and opportunities

6.4.2.Market size and forecast

6.5.Clinical research institutes

6.5.1.Key market trends, growth factors, and opportunities

6.5.2.Market size and forecast

CHAPTER 7:ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY

7.1.Overview

7.1.1.Market size and forecast

7.2.Japan

7.2.1.Market size and forecast, by procedure

7.2.2.Market size and forecast, by service

7.2.3.Market size and forecast, by end user

7.3.India

7.3.1.Market size and forecast, by procedure

7.3.2.Market size and forecast, by service

7.3.3.Market size and forecast, by end user

7.4.China

7.4.1.Market size and forecast, by procedure

7.4.2.Market size and forecast, by service

7.4.3.Market size and forecast, by end user

7.5.Australia

7.5.1.Market size and forecast, by procedure

7.5.2.Market size and forecast, by service

7.5.3.Market size and forecast, by end user

7.6.South Korea

7.6.1.Market size and forecast, by procedure

7.6.2.Market size and forecast, by service

7.6.3.Market size and forecast, by end user

7.7.Thailand

7.7.1.Market size and forecast, by procedure

7.7.2.Market size and forecast, by service

7.7.3.Market size and forecast, by end user

7.8.Malaysia

7.8.1.Market size and forecast, by procedure

7.8.2.Market size and forecast, by service

7.8.3.Market size and forecast, by end user

7.9.Singapore

7.9.1.Market size and forecast, by procedure

7.9.2.Market size and forecast, by service

7.9.3.Market size and forecast, by end user

7.10.New Zealand

7.10.1.Market size and forecast, by procedure

7.10.2.Market size and forecast, by service

7.10.3.Market size and forecast, by end user

7.11.Philippines

7.11.1.Market size and forecast, by procedure

7.11.2.Market size and forecast, by service

7.11.3.Market size and forecast, by end user

7.12.Indonesia

7.12.1.Market size and forecast, by procedure

7.12.2.Market size and forecast, by service

7.12.3.Market size and forecast, by end user

7.13.Rest of Asia-Pacific

7.13.1.Market size and forecast, by procedure

7.13.2.Market size and forecast, by service

7.13.3.Market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.APOLLO HOSPITALS ENTERPRISE LTD.

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Product portfolio

8.1.5.Business performance

8.1.6.Key strategic moves and developments

8.2.CITY FERTILITY

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Operating business segments

8.2.4.Product portfolio

8.2.5.Key strategic moves and developments

8.3.COOPERSURGICAL, INC.

8.3.1.Company overview

8.3.2.Company snapshot

8.3.3.Operating business segments

8.3.4.Product portfolio

8.3.5.Business performance

8.3.6.Key strategic moves and developments

8.4.ESCO LIFE SCIENCES GROUP

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Operating business segments

8.4.4.Product portfolio

8.4.5.Key strategic moves and developments

8.5.FERTILITY ASSOCIATES LIMITED

8.5.1.Company overview

8.5.2.Company snapshot

8.5.3.Operating business segments

8.5.4.Product portfolio

8.6.GENEA LIMITED

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Operating business segments

8.6.4.Product portfolio

8.6.5.Key strategic moves and developments

8.7.MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)

8.7.1.Company overview

8.7.2.Company snapshot

8.7.3.Operating business segments

8.7.4.Product portfolio

8.7.5.Business performance

8.8.MONASH IVF GROUP LIMITED

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Operating business segments

8.8.4.Product portfolio

8.8.5.Business performance

8.8.6.Key strategic moves and developments

8.9.THERMO FISHER SCIENTIFIC INC.

8.9.1.Company overview

8.9.2.Company snapshot

8.9.3.Operating business segments

8.9.4.Product portfolio

8.9.5.Business Performance

8.9.6.Key strategic moves and developments

8.10.VIRTUS HEALTH

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Operating business segments

8.10.4.Product portfolio

8.10.5.Business performance

8.10.6.Key strategic moves and developments

TABLE 01.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 02.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 03.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 04.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)

TABLE 05.JAPAN FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 06.JAPAN FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 07.JAPAN FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 08.INDIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 09.INDIA FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 10.INDIA FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 11.CHINA FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 12.CHINA FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 13.CHINA FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 14.AUSTRALIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 15.AUSTRALIA FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 16.AUSTRALIA FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 17.SOUTH KOREA FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 18.SOUTH KOREA FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 19.SOUTH KOREA FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 20.THAILAND FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 21.THAILAND FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 22.THAILAND FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 23.MALAYSIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 24.MALAYSIA FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 25.MALAYSIA FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 26.SINGAPORE FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 27.SINGAPORE FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 28.SINGAPORE FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 29.NEW ZEALAND FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 30.NEW ZEALAND FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 31.NEW ZEALAND FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 32.PHILIPPINES FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 33.PHILIPPINES FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 34.PHILIPPINES FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 35.INDONESIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 36.INDONESIA FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 37.INDONESIA FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 38.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2020-2030 ($MILLION)

TABLE 39.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2020-2030 ($MILLION)

TABLE 40.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)

TABLE 41.APOLLO HOSPITALS: COMPANY SNAPSHOT

TABLE 42.APOLLO HOSPITALS: OPERATING SEGMENTS

TABLE 43.APOLLO HOSPITALS: PRODUCT PORTFOLIO

TABLE 44.CITY FERTILITY: COMPANY SNAPSHOT

TABLE 45.CITY FERTILITY: PRODUCT PORTFOLIO

TABLE 46.COOPERSURGICAL: COMPANY SNAPSHOT

TABLE 47.COOPERSURGICAL: OPERATING SEGMENTS

TABLE 48.COOPERSURGICAL: PRODUCT PORTFOLIO

TABLE 49.ESCO: COMPANY SNAPSHOT

TABLE 50.ESCO: OPERATING SEGMENTS

TABLE 51.ESCO: PRODUCT PORTFOLIO

TABLE 52.FERTILITY ASSOCIATES: COMPANY SNAPSHOT

TABLE 53.FERTILITY ASSOCIATES: OPERATING SEGMENTS

TABLE 54.FERTILITY ASSOCIATES: PRODUCT PORTFOLIO

TABLE 55.GENEA LIMITED: COMPANY SNAPSHOT

TABLE 56.GENEA LIMITED: OPERATING SEGMENTS

TABLE 57.GENEA LIMITED: PRODUCT PORTFOLIO

TABLE 58.MEDICOVER: COMPANY SNAPSHOT

TABLE 59.MEDICOVER: OPERATING SEGMENTS

TABLE 60.MEDICOVER: PRODUCT PORTFOLIO

TABLE 61.MVF: COMPANY SNAPSHOT

TABLE 62.MVF: PRODUCT PORTFOLIO

TABLE 63.THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 64.THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS

TABLE 65.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 66.VIRTUS HEALTH: COMPANY SNAPSHOT

TABLE 67.VIRTUS HEALTH: OPERATING SEGMENTS

TABLE 68.VIRTUS HEALTH: PRODUCT PORTFOLIO